CoChat

Target selection in drug discovery

Knowles, Jonathan, Gromo, Gianni · 2003 · Nature Reviews Drug Discovery

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Target selection in drug discovery--defined here as the decision to focus on finding an agent with a particular biological action that is anticipated to have therapeutic utility--is influenced by a complex balance of scientific, medical and strategic considerations. In this article, we provide an introduction to the key issues in target selection and discuss the rationale for decision making.

Overview

Integrity signals

Registry

Crossref · 10.1038/nrd986

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 13 · Cited by 216

Research works printed but not linked: 2

  1. Jack, D. in Creating the Right Environment for Drug Discovery (ed. Walker, S. R.) 67–71 (Quay Publishing, Lancaster, 1991).
  2. Jones, R. H. An approach to pricing of innovative research-based medicine. Pharm. Med. 8, 29–38 (1994). An excellent overview that describes the approach used by research-based companies in identifying the right price for a new product.

Metadata

Authors
Knowles, J., & Gromo, G.
Affiliations
F. Hoffmann-La Roche AG (CH)
Corresponding author
  • Knowles, Jonathan
  • Gromo, Gianni
Venue
Nature Reviews Drug Discovery
Published
2003-01
Volume
2
Issue
1
Pages
63-69
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W2803560454
Cited by
216
References
13
Citations by year
2026: 4 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 12 · 2021: 14 · 2020: 12 · 2019: 5 · 2018: 10 · 2017: 4 · 2016: 7 · 2015: 11 · 2014: 11 · 2013: 11 · 2012: 12
FWCI
9.17
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Reviews Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords
target selection, drug discovery, drug target identification, decision-making, drug development strategy
MeSH terms
Biotechnology, Drug Industry, Humans, Legislation, Drug, Pharmacology, Receptors, Drug, Health Care Sector

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Target selection in drug discovery. https://app.cochat.ai/papers/10.1038/nrd986
The paper
Knowles, J., & Gromo, G. (2003). Target selection in drug discovery. Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd986

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.